Menu
Menu
In this episode, Dr. Jurgi Camblong sits down with Dr. Michael Snyder, Chair of Genetics at Stanford Medicine, to challenge the fundamental flaw of modern medicine: we generally wait until people are broken to fix them.
Michael explains why our current system isn't healthcare—it is “sick care.” While we have sophisticated dashboards to monitor our cars and prevent breakdowns, we largely fly blind when it comes to our own biology.
Together, they explore how deep data profiling, AI, and continuous monitoring are rewriting the rules of longevity. From the impact of wearables to the molecular secrets of aging, this conversation maps out a future where we don't just treat disease, but predict and prevent it.
You’ll hear about:
Recorded virtually between Switzerland and Silicon Valley, this episode is a wake-up call for anyone interested in the future of their own longevity—proving that the secret to a longer life lies in the data we generate every day.
"We don't really do healthcare; we do sick care. We treat people when they're ill. My vision is that we should be keeping people healthy... detecting disease at its earliest stage, before you even have symptoms"
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
